• HyperScribe SP6 Kit: Enabling Next-Gen RNA Immunity Research

  2026-06-04

  Explore how the HyperScribe SP6 High Yield RNA Synthesis Kit drives high-fidelity RNA synthesis for advanced immunity studies. This article uniquely bridges mechanistic virology insights and practical assay design.

• RBMS1 Loss Enhances PD-L1 Blockade Response in TNBC Models

  2026-06-04

  The reference study uncovers RBMS1 as a post-transcriptional regulator of PD-L1 in triple-negative breast cancer (TNBC), showing that RBMS1 depletion sensitizes immune-cold tumors to checkpoint blockade. These findings highlight a new strategy to improve immunotherapy outcomes in TNBC by targeting RNA-binding protein-mediated immune evasion.

• Annexin V-FITC/7-AAD Apoptosis Kit: Technical Application Gu

  2026-06-03

  The Annexin V-FITC/7-AAD Apoptosis Kit enables rapid, sensitive discrimination of apoptotic and necrotic cells, streamlining standard cell viability and cytotoxicity assays. It is best suited for use with flow cytometry or fluorescence microscopy in conventional research workflows. This kit is not recommended for mechanistic pathway studies or unconventional cell death investigations.

• Probenecid as a Precision Tool for Immunometabolism and Neur

  2026-06-03

  Explore Probenecid’s unique role as a 4-(dipropylsulfamoyl)benzoic acid-based modulator in immunometabolic research and neuroprotection. This article provides a deeper analysis of its mechanisms and assay impact beyond multidrug resistance.

• 5-HT3 Antagonists Inhibit Renal OCT2 and MATE1 Transporters

  2026-06-02

  This study reveals that 5-HT3 receptor antagonists, including tropisetron, can inhibit the renal organic cation transporters OCT2 and MATE1 in vitro, with potential implications for drug-drug interactions and pharmacokinetics. The findings inform both mechanistic research and experimental assay design in transporter-mediated secretion.

• Actinomycin D in Translational Research: Mechanisms to Impac

  2026-06-02

  This thought-leadership article examines Actinomycin D (ActD) as an essential tool for translational researchers. We explore mechanistic insights into DNA intercalation and transcriptional inhibition, contextualize recent findings on transcriptional stress and cellular responses, and offer strategic guidance for deploying ActD in advanced molecular workflows. Drawing on both foundational principles and emerging research—including the interplay between phase separation, ER stress, and gene regulation—we position APExBIO’s Actinomycin D as a benchmark compound for dissecting apoptosis, mRNA stability, and the DNA damage response in cancer and beyond.

• Urolithin A in Precision Mitochondrial Research: Mechanisms

  2026-06-01

  Explore how Urolithin A, a gut microbiota-derived metabolite, is advancing mitochondrial biogenesis research and skeletal muscle gene modulation. This article uniquely connects mechanistic insights with actionable protocols and the latest reference breakthroughs.

• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-06-01

  Song et al. uncover how murine norovirus leverages NINJ1, a plasma membrane rupture effector, to selectively export the viral NS1 protein via a regulated, unconventional secretory pathway. This work provides new mechanistic insight into host-pathogen interactions, apoptosis, and the specificity of large protein release during infection.

• circUSP10 as a Diagnostic Biomarker in Early-Stage NSCLC

  2026-05-31

  Bai et al. identify circUSP10, a circular RNA, as a promising diagnostic biomarker for early-stage non-small-cell lung cancer (NSCLC), demonstrating its stability and elevated expression in patient blood samples. This discovery offers a potential tool for improving early detection and may inform future RNA-based therapeutic strategies.

• Advanced Protocols for Plant Protein Secretion and pH Sensin

  2026-05-30

  The second edition of 'Plant Protein Secretion: Methods and Protocols' delivers rigorously validated, stepwise procedures for dissecting plant-specific protein secretion pathways. By integrating detailed workflows, troubleshooting guidance, and support for live-cell readouts such as intracellular pH measurement, this reference advances reproducibility and mechanistic insight in plant cell biology.

• D-Luciferin Sodium Salt: Optimizing Firefly Luciferase Workf

  2026-05-29

  D-Luciferin sodium salt from APExBIO is the benchmark substrate for sensitive, quantitative bioluminescence imaging in live-cell and in vivo assays. This article bridges recent advances in CAR macrophage immunotherapy with practical assay design, troubleshooting, and data-driven optimization for cell viability and metabolism research.

• Taltirelin Acetate: Applied Protocols and Breakthroughs in N

  2026-05-29

  Taltirelin acetate stands out as a long-acting TRH analog, advancing preclinical research in neuroprotection, itch, and sleep apnea. This guide translates key findings into optimized workflows, troubleshooting strategies, and actionable protocol enhancements for robust experimental outcomes.

• HyperScript™ Reverse Transcriptase: Advancing cDNA Synthesis

  2026-05-28

  HyperScript™ Reverse Transcriptase from APExBIO sets a new benchmark for cDNA synthesis, excelling with challenging RNA templates and low-copy targets. Its engineered thermal stability and high affinity drive robust performance in advanced qPCR and transcriptomics applications.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit in Nucleic Ac

  2026-05-28

  Discover how the HyperScribe T7 High Yield Cy3 RNA Labeling Kit transforms RNA probe synthesis for advanced fluorescence imaging and mechanistic studies. This article reveals unique insights into probe design, regulatory RNA detection, and practical assay strategies, distinguishing itself from standard protocol guides.

• Helper-Polymer FNPs Enable Stable, Lung-Targeted mRNA Delive

  2026-05-27

  The reference study introduces five-element nanoparticles (FNPs) leveraging poly(β-amino esters) as helper polymers to achieve lung-specific mRNA delivery with remarkable post-lyophilization stability. These findings provide a potential solution to longstanding barriers in mRNA therapeutics for pulmonary diseases, notably overcoming the instability of traditional lipid nanoparticles.

16029 records 1/1069 page Next 12345 下5页 Last page